| |
Oded Ben-Joseph, Ph.D.
Executive-in-Residence
Boston, MA
oben-joseph@oxbio.com |
Oded Ben-Joseph, Ph.D., MBA brings significant executive, entrepreneurial and transactional experience to his role as Executive-in-Residence at Oxford Bioscience Partners. Dr. Ben-Joseph was formerly CEO and co-founder of Caliber Therapeutics, Inc., engaged in the development of catheter-based drug delivery products for the intervention of atherosclerotic diseases. His past managerial and entrepreneurial positions included President and CEO of X-Cell Medical, Inc., a clinical stage drug/device convergence company engaged in the development of novel stent-based anti-restenotic drugs, President of Ester Neurosciences, a clinical stage biotech company engaged in the development of novel compounds for the treatment of neurological diseases and CEO and co-founder of Biolight Phototherapy, a company engaged in the development of medical devices for the treatment of dermatological disorders and allergies. He was also Assistant Professor at the Departments of Radiology and Neuroscience at the University of Michigan, a visiting Associate Professor at Tokushima University in Japan and a Visiting Scientist at Parke-Davis. Dr. Ben-Joseph has published over 30 peer-review papers and has received numerous awards and scholarships. He graduated with Honors from Imperial College of Science, Technology and Medicine (U.K.) and received his Ph.D. from Cambridge University (U.K). He completed his post-doctoral training at University of Michigan and received an MBA magna cum laude from University of Bradford.
Back to OBP Team
|
|